Evidence map›Paper›PMID 36741977›Full record

ArticleFrontiers in cellular and infection microbiology2022

Multiple pathways of SARS-CoV-2 nosocomial transmission uncovered by integrated genomic and epidemiological analyses during the second wave of the COVID-19 pandemic in the UK.

Kate F Cook, Angela H Beckett, Sharon Glaysher, Salman Goudarzi, Christopher Fearn, Katie F Loveson, Scott Elliott, Sarah Wyllie, Allyson Lloyd, Kelly Bicknell and 4 more

Open access · goldAbstract read
In one paragraph

Article in Frontiers in cellular and infection microbiology, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
1.9field-weighted citation impact, top 15% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed, 10 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

14 authors at 2 institutions in 1 country.

Kate F CookSchool of Pharmacy and Biomedical Science, University of Portsmouth, Portsmouth, United Kingdom.
Angela H BeckettSchool of Biological Science, University of Portsmouth, Portsmouth, United Kingdom.
Sharon GlaysherPortsmouth Hospitals University NHS Trust, Portsmouth, United Kingdom.
Salman GoudarziSchool of Pharmacy and Biomedical Science, University of Portsmouth, Portsmouth, United Kingdom.
Christopher FearnSchool of Pharmacy and Biomedical Science, University of Portsmouth, Portsmouth, United Kingdom.
Katie F LovesonSchool of Pharmacy and Biomedical Science, University of Portsmouth, Portsmouth, United Kingdom.
Scott ElliottPortsmouth Hospitals University NHS Trust, Portsmouth, United Kingdom.
Sarah WylliePortsmouth Hospitals University NHS Trust, Portsmouth, United Kingdom.
Allyson LloydPortsmouth Hospitals University NHS Trust, Portsmouth, United Kingdom.
Kelly BicknellPortsmouth Hospitals University NHS Trust, Portsmouth, United Kingdom.
Sally LumleyPortsmouth Hospitals University NHS Trust, Portsmouth, United Kingdom.
Anoop J ChauhanPortsmouth Hospitals University NHS Trust, Portsmouth, United Kingdom.
Samuel C RobsonSchool of Pharmacy and Biomedical Science, University of Portsmouth, Portsmouth, United Kingdom.
COVID-19 Genomics UK (COG-UK) consortium
Portsmouth Hospitals NHS Trust · GBUniversity of Portsmouth · GB

Funding

Medical Research Council MC_PC_19027Wellcome Trust
6 · The paper itself

Abstract

Introduction: Throughout the global COVID-19 pandemic, nosocomial transmission has represented a major concern for healthcare settings and has accounted for many infections diagnosed within hospitals. As restrictions ease and novel variants continue to spread, it is important to uncover the specific pathways by which nosocomial outbreaks occur to understand the most suitable transmission control strategies for the future. Methods: In this investigation, SARS-CoV-2 genome sequences obtained from 694 healthcare workers and 1,181 patients were analyzed at a large acute NHS hospital in the UK between September 2020 and May 2021. These viral genomic data were combined with epidemiological data to uncover transmission routes within the hospital. We also investigated the effects of the introduction of the highly transmissible variant of concern (VOC), Alpha, over this period, as well as the effects of the national vaccination program on SARS-CoV-2 infection in the hospital. Results: Our results show that infections of all variants within the hospital increased as community prevalence of Alpha increased, resulting in several outbreaks and super-spreader events. Nosocomial infections were enriched amongst older and more vulnerable patients more likely to be in hospital for longer periods but had no impact on disease severity. Infections appeared to be transmitted most regularly from patient to patient and from patients to HCWs. In contrast, infections from HCWs to patients appeared rare, highlighting the benefits of PPE in infection control. The introduction of the vaccine at this time also reduced infections amongst HCWs by over four-times. Discussion: These analyses have highlighted the importance of control measures such as regular testing, rapid lateral flow testing alongside polymerase chain reaction (PCR) testing, isolation of positive patients in the emergency department (where possible), and physical distancing of patient beds on hospital wards to minimize nosocomial transmission of infectious diseases such as COVID-19.

Indexed as

COVID-19Cross InfectionGenomicsHumansPandemicsSARS-CoV-2United Kingdomalpha variantCOVID-19hospital-acquired infectionnosocomial infectionOxford Nanopore Technologies (ONT)SARS-CoV-2transmission dynamicswhole genome sequencing (WGS)

Identifiers

PMID36741977
PMCPMC9895378
OpenAlexW4317630231

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.